Brown-Forman India MD tracks US trade deal as full-portfolio imports face inflation, tariff risk
MD Gaurav Sabharwal flags India-US trade deal as critical for Brown-Forman's fully imported portfolio. Q4 net sales hit $912M (+2%) but operating income fell 53%. India bets on Woodford Reserve, Herradura premiumisation and slow RTD rollout of Jack & Coke amid 20M LDA additions/year.
What happened
Brown-Forman India MD Gaurav Sabharwal is closely tracking India-US trade deal progress, given full-portfolio imports. He flagged inflation pressure on
Key facts
- $912 million Q4 net sales
- 2% sales growth
- 53% operating income decline
- $15 billion Sazerac offer
- 20 million LDA additions/year
Why this matters
Evaluate local bottling JVs or contract manufacturing partners in India to hedge tariff risk and accelerate RTD scale into the 20M annual LDA cohort before competitors lock in premium shelf space.